MANILA, Philippines -- By Lee Han-soo / Korea Biomedical Review correspondent --Idiopathic pulmonary fibrosis (IPF) remains one of the most devastating respiratory diseases, with limited treatment options and poor long-term outcomes despite recent advances.Existing antifibrotic drugs -- pirfenidone
The long-standing prejudice that HIV is a death sentence has finally ended. Fear once grew from ignorance, but science has built a solid bridge over that ignorance. Now, the task remains for Korean society to cross that bridge.At the “Red Period, With You” campaign event last Friday, tension and war
The gremlins were cute. That is what Anna Lembke said when asked about why her most famous book "Dopamine Nation" landed so hard in Korea.In her book, the “gremlins” are tiny creatures that symbolize the brain’s natural pushback against pleasure — the inner forces that tip the balance toward pain wh
At the Korean Society of Medical Oncology (KSMO) 2025 meeting in Seoul on Thursday, the momentum behind cancer vaccines was on full display as researchers pointed to stronger scientific foundations and maturing manufacturing platforms that are bringing the long-discussed field closer to clinical rea
The Korean Society of Medical Oncology (KSMO) opened its 20th anniversary international conference, KSMO 2025, from Wednesday to Friday at the Grand Walkerhill Seoul.Under the theme “Excellence, Innovation, and Hope in Cancer Care,” the three-day meeting brings together oncologists and researchers f
The 18th Annual Meeting of the Korean Society of Medical Oncology & 2025 International Conference (KSMO2025), which will be held at the Grand Walkerhill Seoul from Sept. 3-5, will be more than an academic gathering.Marking the society’s 20th anniversary, this year’s event aims to bridge generations,
BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- In the rapidly evolving landscape of oncology, where scientific breakthroughs emerge at breakneck speed and competition intensifies daily, Merck KGaA stands at a pivotal moment. The German pharmaceutical giant, long celebrate
BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- Cytiva, a global life sciences company, is broadening its influence across the Asia-Pacific region, strengthening local manufacturing, supply chain resilience, and customer partnerships to keep pace with the region’s rapidly
JAMA’s top editors landed in Seoul early Tuesday with a clear message for Korean researchers: the door is open, but the bar is high -- and if you’re using artificial intelligence, don’t lie about it. They delivered that message the next afternoon in a joint lecture at Korea University College of Med
In the crowded landscape of botulinum toxin products, Botox continues to maintain its position as the undisputed market leader in the botulinum toxin segment.In 2024, AbbVie reported global Botox revenues of approximately $2.7 billion in aesthetics and $3.2 billion in therapeutic use -- totaling ab
At the "Cutting-Edge Diagnostic Techniques in Hematology" session of the International Congress of the Korean Society of Hematology (ICKSH) 2025, held on March 28 at the Grand Walkerhill Seoul, experts focused on how precision diagnostic technologies in hematologic malignancies are evolving.The sess
The International Congress of the Korean Society of Hematology (ICKSH) 2025, held on March 28 at the Grand Walkerhill Seoul, featured an educational session titled “Basic Understanding and Application of AI” to highlight the latest advances in artificial intelligence, which is increasingly being app
The Korean Society of Medical Oncology (KSMO), celebrating its 20th anniversary this year, will host KSMO 2025 -- the 18th Annual Meeting of the Korean Society of Medical Oncology and the 2025 International Conference -- from Sept. 3 to 5 at the Grand Walkerhill Hotel in Seoul.Building on last year’
As acute myeloid leukemia (AML) treatment evolves from broad-spectrum cytotoxic approaches to personalized, molecularly guided therapies, global experts are emphasizing the need to redefine risk assessment, therapeutic timing, and post-treatment monitoring.The increased integration of genomic profil
As chronic myeloid leukemia (CML) care increasingly moves beyond single-gene testing, next-generation sequencing (NGS) is emerging as a new clinical standard, offering deeper insights into resistance mechanisms, treatment failure, and disease progression. While BCR::ABL1 fusion monitoring has long b
Chronic myeloid leukemia (CML) treatment is entering a new phase of precision-tailored strategies, with the rise of asciminib and genomic profiling marking a turning point in frontline therapy and long-term disease control.Speaking with Korea Biomedical Review during the International Congress of th
As CD38 emerges as a central immuno-oncology target, its multifunctional role in immune signaling, NAD metabolism, and tumor microenvironment modulation has attracted growing scientific and clinical attention.In recent years, CD38-targeting monoclonal antibodies such as daratumumab (product name: Da
"Clinical outcomes alone are not enough. We must also consider how a new drug affects the patient’s life and its broader societal impact."These are the words of Professor Andrew Davies, Chair of the UK National Cancer Institute Lymphoma Research Group and Professor of Haematological Oncology at Univ
High-risk pediatric acute myeloid leukemia (HR-AML) remains one of the most challenging hematologic malignancies in children, with long-term survival still lagging behind despite decades of therapeutic development.While overall outcomes in pediatric AML have improved to 65–70 percent, relapse and tr
Myeloid leukemia associated with Down syndrome (ML-DS) is a unique subtype of acute myeloid leukemia (AML) occurring predominantly in children with Down syndrome.Notably, children with ML-DS generally exhibit a favorable prognosis, with event-free survival rates approaching 90 percent. This improved
